Exploration of nanomedicine market

28 June 2009

Nanomedicine is one of the branch of nanotechnology where thousands of researchers working hard day and night to explore the use of this branch for treating many diseases including life-threatening diseases. Many applications of nanomedicine such as nanobiomaterial, nano drug delivery and nanopharmaceuticals are on the fast track, which will enhance the efficacy and at the same time significantly minimizes the risks associated with standard therapeutics.

In the last couple of years many new novel products in the area of nanobiomaterial especially in the form of coatings have successfully come out from clinical research. Some of these are now available commercially and plays a key role in the area of health care application.

Another major area of nanomedicine is the drug delivery and which is the largest application area and it is expected to grow at a faster pace within the next five years. A lot of research in this area is underway since the last four years and we will see the outcome in the form of many process technologies suitable for treating life-threatening diseases including cancer in the next couple of years.

Key players in nanomedicine market include Nanosphere Inc., Par Pharmaceutical Companies Inc., AMAG Pharmaceutical Inc., Elan Corporation PLC, Life Technologies Corporation, Abraxis BioScience Inc., Flamel Technologies S.A., Oxonica Plc, Wyeth Pharmaceuticals Inc., and Arrowhead Research Corporation.

Related Posts: